The Kaiser Family Foundation
The Kaiser Family Foundation is non-profit, private operating foundation dedicated to providing information and analysis on health care issues to policymakers, the media, the health care community and the general public. The Foundation is not associated with Kaiser Permanente or Kaiser Industries.
National Institute of Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 50 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world.
DAIDS The Division of Acquired Immune Deficiency Syndrome
DAIDS is a Division within the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) in Bethesda, MD. DAIDS was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Specifically, the mission of DAIDS is to help ensure an end to the HIV/AIDS epidemic by increasing basic knowledge of the pathogenesis and transmission of the human immunodeficiency virus (HIV), supporting the development of therapies for HIV infection and its complications and co-infections, and supporting the development of vaccines and other prevention strategies.
VRC The Dale and Betty Bumpers Vaccine Research Center
The VRC conducts preventive HIV vaccine research and development at a facility located on the campus of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) in Bethesda, MD. The VRCâ€™s research is funded by the United States Department of Health and Human Services.
HVTN The HIV Vaccine Trials Network
The HVTN is an international organization of scientists and educators who have come together to develop a safe and effective preventive HIV vaccine. It facilitates the production and testing of vaccines against HIV/AIDS and conducts all phases of clinical evaluation, from testing experimental vaccines for safety to testing the effectiveness of vaccines in preventing HIV. The HVTN was created in 1999 by the Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH).
IAVI International AIDS Vaccine Initiative
IAVI is a global not-for-profit organization working to speed the search for a vaccine to prevent HIV infection and AIDS. Founded in 1996 and operational in 23 countries, IAVI and its network of partners research and develop vaccine candidates. IAVI also advocates for a vaccine to be a global priority and works to ensure that a future vaccine will be accessible to all who need it.
AVAC The AIDS Vaccine Advocacy Coalition
A community-based organization, AVAC has been working for 10 years to accelerate the ethical development and global delivery of vaccines against HIV/AIDS. AVAC provides independent analysis of developments in HIV/AIDS prevention and treatment, public education on vaccine research, policy advocacy, and helps local communities support and stay informed about HIV vaccine clinical trials.
USAID United States Agency for International Development
USAID provides support to the International AIDS Vaccine Initiative (IAVI), a non-governmental organization, to accelerate the development of an effective vaccine for HIV prevention. USAID funds are used to support Vaccine Development Partnerships that are focused on advancing HIV vaccine candidates to clinical trials. Among the activities supported within a five-year Cooperative Agreement are site development and community preparations for HIV vaccine efficacy trials in developing countries and public policy research to accelerate and support HIV vaccine research/development and future access. Vaccine clinical trial centers have been established in Kenya, Uganda, Rwanda, Zambia, South Africa, and India.
USMHRP – U.S. Military HIV Research Program
USMHRP is a tri-service research effort striving to develop a globally effective and safe HIV vaccine to protect at-risk military and civilian populations and to improve public health worldwide. The Program is headed by the Walter Reed Army Institute of Research in collaboration with the Henry M. Jackson Foundation for the Advancement of Military Medicine. USMHRP is dedicated to HIV vaccine development, prevention, disease surveillance, and care and treatment for HIV.
AIDSinfo is a U.S. Department of Health and Human Services (HHS) project that offers the latest federally approved information on HIV/AIDS clinical research, treatment and prevention, and medical practice guidelines for people living with HIV/AIDS, their families and friends, health care providers, and researchers. AIDSinfo serves as the main dissemination point for federally approved HIV treatment and prevention guidelines, and provides information on clinical research trials for HIV infected patients. All of the information provided by AIDSinfo is from federal government agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, Health Resources and Services Administration among others.